FDA confirms safety, efficacy of single-shot Johnson & Johnson vaccine
Deliveroo to launch in Burnley next month
B2B ecommerce- Unlocking the potential of thousands of MSMEs in India, Retail News, ET Retail
Karnataka planning fund for start-ups in engineering colleges
Jokowi highlights condition to surpass growth forecast in 2021
Maintenance key to functioning farms
CAPF canines to undergo annual evaluation
Is trade deal with China a dangerous move for EU?
Ash ElDifrawi joins TheMathCompany's advisory board, all Set to accelerate their brand growth and global presence
Bello to tell Duterte next week about UK gov’t’s answer to vaccine request for Pinoy nurses – Manila Bulletin
Rwanda: Govt Earmarks Rwf1 Billion for Settlement of Longstanding Arrears of Ex-Employees
GBP/AUD, GBP/NZD, GBP/CAD Under Pressure
Official Images & Release Info
Rahul Gandhi takes dip in Arabian Sea with fishermen
Old Wye Mill releases tree-ring study
Khoi and San celebrate airport name change in Gqeberha
Darshan Roberrt Pre-release Event In Hyderabad
Would you pay extra for S Pen support on your current smartphone?
Nigerians Consume 80 Terabytes Of Data Monthly - NCC
Antibiotice Iasi Net Profit Drops 16% in 2002, to RON25M
ETHS students host workshop on 5th Ward school
Africa: Risk of Severe Covid Established Early in Infection
Scientists also discovered that these patients have changes in some cytokines - proteins that orchestrate the immune response.But the damage to the body's organs is not caused by the virus itself but by the immune system's response to the virus.Finding out who is at risk of this runaway immune response, before symptoms kick in, is important.The researchers, from the University of Cambridge, found that very early changes in the immune response to the virus could be used to predict who will develop severe disease and who won't.
On the other hand, patients with mild disease or no symptoms were found to mount an early and robust adaptive immune response to the virus.An adaptive immune response is where the immune system identifies an infection and then produces T cells, B cells and antibodies specific to the virus to fight back.